AFC-HD AMS Life Science Co., Ltd.(JP:2927)
Â¥835.000.00 (0.00%)
JP:2927
AFC-HD AMS Life Science Co., Ltd. financials statements
Â¥835.00
At close:0.00 (0.00%)
Want to see JP:2927 full AI Analyst Report?
AFC-HD AMS Life Science Co., Ltd. (2927) Ratios
0 Followers
AFC-HD AMS Life Science Co., Ltd. Ratios
JP:2927's free cash flow for Q4 2026 was ¥0.00. For the 2026 fiscal year, JP:2927's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Aug 26 | Aug 25 | Aug 24 | Aug 23 | Aug 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.84 | 0.86 | 1.25 | 1.34 | 1.30 |
| Quick Ratio | 0.55 | 0.59 | 0.91 | 1.04 | 1.01 |
| Cash Ratio | 0.38 | 0.43 | 0.69 | 0.75 | 0.79 |
| Solvency Ratio | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 |
| Operating Cash Flow Ratio | 0.06 | 0.07 | 0.09 | 0.06 | 0.11 |
| Short-Term Operating Cash Flow Coverage | 0.09 | 0.10 | 0.16 | 0.11 | 0.21 |
| Net Current Asset Value | ¥ -10.79B | ¥ -11.20B | ¥ -10.98B | ¥ -8.04B | ¥ -7.78B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.50 | 0.49 | 0.48 | 0.46 |
| Debt-to-Equity Ratio | 1.44 | 1.60 | 1.64 | 1.49 | 1.38 |
| Debt-to-Capital Ratio | 0.59 | 0.62 | 0.62 | 0.60 | 0.58 |
| Long-Term Debt-to-Capital Ratio | 0.22 | 0.27 | 0.49 | 0.46 | 0.45 |
| Financial Leverage Ratio | 3.03 | 3.23 | 3.38 | 3.13 | 3.00 |
| Debt Service Coverage Ratio | 0.17 | 0.16 | 0.25 | 0.26 | 0.25 |
| Interest Coverage Ratio | 9.18 | 11.83 | 18.92 | 28.43 | 17.62 |
| Debt to Market Cap | 1.85 | 1.99 | 1.95 | 1.75 | 1.59 |
| Interest Debt Per Share | 1637.00 | 1730.57 | 1634.59 | 1395.32 | 1223.50 |
| Net Debt to EBITDA | 3.48 | 3.38 | 3.46 | 3.23 | 2.94 |
| Profitability Margins | |||||
| Gross Profit Margin | 33.95% | 33.59% | 34.76% | 36.45% | 37.30% |
| EBIT Margin | 7.13% | 7.36% | 6.67% | 6.27% | 5.62% |
| EBITDA Margin | 11.43% | 11.64% | 10.26% | 10.12% | 10.00% |
| Operating Profit Margin | 7.13% | 7.29% | 6.35% | 6.40% | 4.41% |
| Pretax Profit Margin | 5.74% | 6.74% | 6.33% | 6.04% | 5.37% |
| Net Profit Margin | 3.49% | 4.44% | 4.15% | 4.31% | 3.20% |
| Continuous Operations Profit Margin | 3.50% | 4.50% | 4.13% | 4.33% | 3.21% |
| Net Income Per EBT | 60.90% | 65.81% | 65.53% | 71.32% | 59.52% |
| EBT Per EBIT | 80.45% | 92.48% | 99.72% | 94.48% | 121.72% |
| Return on Assets (ROA) | 2.44% | 2.97% | 2.66% | 2.68% | 1.97% |
| Return on Equity (ROE) | 7.40% | 9.61% | 8.99% | 8.41% | 5.91% |
| Return on Capital Employed (ROCE) | 10.54% | 10.47% | 6.52% | 6.24% | 4.21% |
| Return on Invested Capital (ROIC) | 3.55% | 3.85% | 3.20% | 3.40% | 1.94% |
| Return on Tangible Assets | 2.52% | 3.10% | 2.81% | 2.78% | 2.05% |
| Earnings Yield | 9.50% | 12.02% | 10.69% | 9.86% | 6.80% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.26 | 11.15 | 10.65 | 9.04 | 8.97 |
| Payables Turnover | 6.97 | 5.99 | 5.49 | 4.98 | 4.22 |
| Inventory Turnover | 2.96 | 3.09 | 3.29 | 3.73 | 3.87 |
| Fixed Asset Turnover | 1.54 | 1.53 | 1.55 | 1.49 | 1.44 |
| Asset Turnover | 0.70 | 0.67 | 0.64 | 0.62 | 0.62 |
| Working Capital Turnover Ratio | -8.95 | 81.14 | 6.36 | 5.73 | 5.78 |
| Cash Conversion Cycle | 106.46 | 89.94 | 78.65 | 65.00 | 48.62 |
| Days of Sales Outstanding | 35.58 | 32.72 | 34.27 | 40.36 | 40.68 |
| Days of Inventory Outstanding | 123.22 | 118.20 | 110.86 | 97.96 | 94.38 |
| Days of Payables Outstanding | 52.34 | 60.98 | 66.47 | 73.32 | 86.43 |
| Operating Cycle | 158.80 | 150.93 | 145.13 | 138.32 | 135.05 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 116.03 | 127.03 | 109.49 | 61.61 | 106.21 |
| Free Cash Flow Per Share | -50.22 | -124.55 | -132.71 | -76.50 | 38.03 |
| Dividend Paid and CapEx Coverage Ratio | 0.57 | 0.45 | 0.40 | 0.37 | 1.08 |
| Capital Expenditure Coverage Ratio | 0.70 | 0.50 | 0.45 | 0.45 | 1.56 |
| Operating Cash Flow Coverage Ratio | 0.07 | 0.07 | 0.07 | 0.04 | 0.09 |
| Operating Cash Flow to Sales Ratio | 0.05 | 0.05 | 0.05 | 0.03 | 0.06 |
| Free Cash Flow Yield | -5.75% | -14.53% | -15.93% | -9.61% | 4.94% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.53 | 8.32 | 9.36 | 10.14 | 14.71 |
| Price-to-Sales (P/S) Ratio | 0.37 | 0.37 | 0.39 | 0.44 | 0.47 |
| Price-to-Book (P/B) Ratio | 0.78 | 0.80 | 0.84 | 0.85 | 0.87 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.38 | -6.88 | -6.28 | -10.40 | 20.25 |
| Price-to-Operating Cash Flow Ratio | 7.52 | 6.75 | 7.61 | 12.92 | 7.25 |
| Price-to-Earnings Growth (PEG) Ratio | -0.54 | 0.53 | 0.70 | 0.20 | -0.29 |
| Enterprise Value Multiple | 6.70 | 6.55 | 7.24 | 7.55 | 7.64 |
| Enterprise Value | 26.27B | 24.89B | 22.44B | 19.53B | 17.58B |
| EV to EBITDA | 6.70 | 6.55 | 7.24 | 7.55 | 7.64 |
| EV to Sales | 0.77 | 0.76 | 0.74 | 0.76 | 0.76 |
| EV to Free Cash Flow | -36.17 | -14.21 | -12.02 | -18.18 | 32.89 |
| EV to Operating Cash Flow | 15.66 | 13.93 | 14.57 | 22.58 | 11.78 |
| Tangible Book Value Per Share | 1029.79 | 937.07 | 813.40 | 838.53 | 781.98 |
| Shareholders’ Equity Per Share | 1120.42 | 1071.79 | 990.57 | 933.44 | 885.22 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.39 | 0.33 | 0.35 | 0.28 | 0.40 |
| Revenue Per Share | 2373.15 | 2321.45 | 2145.91 | 1821.40 | 1636.58 |
| Net Income Per Share | 82.89 | 102.98 | 89.01 | 78.51 | 52.33 |
| Tax Burden | 0.61 | 0.66 | 0.66 | 0.71 | 0.60 |
| Interest Burden | 0.80 | 0.92 | 0.95 | 0.96 | 0.96 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| SG&A to Revenue | 0.27 | 0.26 | 0.25 | 0.26 | 0.28 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.40 | 1.23 | 0.81 | 0.56 | 1.21 |
Currency in JPY

